Detalles de la búsqueda
1.
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial.
J Endovasc Ther
; 25(2): 158-168, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29552984
2.
A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
J Endovasc Ther
; 22(2): 261-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25809373
3.
Rationale and design of the TAXUS Liberte Post-Approval Study: examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practice.
Am Heart J
; 163(2): 142-8.e6, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22305829
4.
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
J Gen Intern Med
; 23(5): 509-16, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18228109
5.
Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by clinicians.
J Clin Hypertens (Greenwich)
; 10(11): 822-9, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19128270
6.
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
Am Heart J
; 153(1): 42-53, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17174636
7.
Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.
Am J Cardiol
; 99(12A): 90i-102i, 2007 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-17599429
8.
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Ann Intern Med
; 144(3): 172-80, 2006 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-16461961
9.
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
J Clin Hypertens (Greenwich)
; 8(9): 649-56; quiz 657-8, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16957427
10.
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med
; 165(12): 1401-9, 2005 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-15983290
11.
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med
; 165(8): 936-46, 2005 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15851647
12.
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Arch Intern Med
; 164(9): 969-76, 2004 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15136305
13.
Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
J Clin Hypertens (Greenwich)
; 5(6): 377-84, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14688492
14.
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
J Clin Hypertens (Greenwich)
; 4(6): 393-404, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12461301
15.
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
J Hematol Oncol
; 6: 17, 2013 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23414938
16.
Re: Hawkins RG, Houston MC Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005 Jun;18(6):744-9.
Am J Hypertens
; 19(6): 656-7, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16733244
17.
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Diabetes Care
; 31(2): 353-60, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18000186
18.
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Hypertension
; 48(3): 374-84, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16864749
Resultados
1 -
18
de 18
1
Próxima >
>>